Early combination therapy with etanercept and methotrexate in JIA patients shortens the time to reach an inactive disease state and remission: results of a double-blind placebo-controlled trial

• Main Authors: Ekaterina Alexeeva (Author), Gerd Horneff (Author), Tatyana Dvoryakovskaya (Author), Rina Denisova (Author), Irina Nikishina (Author), Elena Zholobova (Author), Viktor Malievskiy (Author), Galina Santalova (Author), Elena Stadler (Author), Larisa Balykova (Author), Yuriy Spivakovskiy (Author), Ivan Kriulin (Author), Alina Alshevskaya (Author), Andrey Moskalev (Author)
• Format: Book
• Published: BMC, 2021-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Remission is the primary objective of treating juvenile idiopathic arthritis (JIA). It is still debatable whether early intensive treatment is superior in terms of earlier achievement of remission. The aim of this study was to evaluate the effectiveness of early etanercept+methot...